Biblio Discovery — Demo Discovery Service

19 results for "Daichi Inoue"

Showing 1–19 · 0.31 seconds · RSS

  1. Journal Article

    Successful outcome of a pregnancy derived from premature ovulation in a gonadotropin‐releasing hormone antagonist protocol: A case report

    Daichi Inoue; Yoshimasa Asada; Tomoko Ando

    Clinical Case Reports, Vol. 9 No. 2 · 2021 · English · DOAJ Dropped by Scopus 2021

    Abstract In the gonadotropin‐releasing hormone (GnRH) antagonist protocol, it is necessary to reinforce contraceptive guidance assuming that luteinizing hormone surge is not detected by measurement of serum level and ovulation is not suppressed by GnRH antagonist.

  2. Journal Article

    CLINICAL ANALYSIS AND OPTIMIZATION OF POST-REMISSION THERAPY FOR ACUTE MYELOID LEUKEMIA PATIENTS WITH MINIMAL RESIDUAL DISEASE AS DETERMINED BY FLOW CYTOMETRY

    Daichi Inoue; Hayato Maruoka; Takayuki Takahashi

    Mediterranean Journal of Hematology and Infectious Diseases, Vol. 2 No. 2 · 2010 · English · DOAJ Scopus

    Background: Although several prognostic indicators of de novo acute myeloid leukemia (AML) patients have been identified, the clinical significance of minimal residual disease (MRD) needs to be evaluated further in Japanese adult patients. Methods: Using three color flow cytometry, we identified…

  3. Journal Article

    CLINICAL ANALYSIS AND OPTIMIZATION OF POST-REMISSION THERAPY FOR ACUTE MYELOID LEUKEMIA PATIENTS WITH MINIMAL RESIDUAL DISEASE AS DETERMINED BY FLOW CYTOMETRY

    Hayato Maruoka; Daichi Inoue; Takayuki Takahashi

    Mediterranean Journal of Hematology and Infectious Diseases, Vol. 2 No. 2 · 2010 · English · DOAJ Scopus

    <p class="MsoNormal" style="margin: 0mm 0mm 0pt;"><span style="font-family: Times New Roman;"><strong style="mso-bidi-font-weight: normal;"><span style="font-size: 12pt; color: windowtext;" lang="EN-US">Background</span></strong><span style="font-size: 12pt; color: windowtext;" lang="EN-US">…

  4. Book Chapter Full text

    Bacillus cereus Sepsis in the Treatment of Acute Myeloid Leukemia

    Daichi Inoue; Takayuki Takahashi

    Myeloid Leukemia - Clinical Diagnosis and Treatment · 2012 · English · IntechOpen

  5. Journal Article

    Clinical utility of chlormadinone acetate (Lutoral™) in frozen‐thawed embryo transfer with hormone replacement

    Yoshimasa Asada; Yoshiki Hashiba; Yukio Hattori et al.

    Reproductive Medicine and Biology, Vol. 18 No. 3 · 2019 · English · DOAJ Scopus

    Abstract Purpose The clinical utility of chlormadinone acetate tablets (Lutoral™), an orally active progestin which has been available since June 2007, was compared to an in‐house vaginal suppository formulation of progesterone used between 2006 and 2007 for assisted reproductive technology (ART)…

  6. Journal Article

    Investigation of a simple suspension method for orexin receptor antagonist tablets

    Kazuhiro Hada; Daichi Inoue; Kouyou Ohishi et al.

    Journal of Pharmaceutical Health Care and Sciences, Vol. 12 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background A simple suspension method is used in medical practice to administer several orexin receptor antagonists for patients with dysphagia; however, detailed suspension and passage through catheter evaluations have not been performed. Therefore, to safely administer orexin receptor…

  7. Journal Article

    Two-year cumulative live-birth rates and maximum number of transfer cycles in women aged ≥ 40 years

    Sakiko Nukaga; Mikiko Tokoro; Emiko Asano et al.

    Scientific Reports, Vol. 14 No. 1 · 2024 · English · DOAJ Scopus

    Abstract This retrospective study aimed to clarify the cumulative live-birth rates (CLBRs) and cost per live-birth (LB) to evaluate the validity of frozen–thawed embryo transfer without preimplantation genetic testing for aneuploidy (PGT-A) in women aged ≥ 40 years. The study included 1,011…

  8. Journal Article

    Performance of anti‐Müllerian hormone (AMH) levels measured by Beckman Coulter Access AMH assay to predict oocyte yield following controlled ovarian stimulation for in vitro fertilization

    Yoshimasa Asada; Miyako Tsuiki; Megumi Sonohara et al.

    Reproductive Medicine and Biology, Vol. 18 No. 3 · 2019 · English · DOAJ Scopus

    Abstract Purpose We evaluated the performance of anti‐Müllerian hormone (AMH) measured by the Beckman Coulter fully automated Access assay to predict oocyte yield following controlled ovarian stimulation (COS) for in vitro fertilization (IVF). Methods The correlation between the Access assay and…

  9. Journal Article

    Risk factors for empty follicle syndrome in assisted reproductive technology with gonadotropin‐releasing hormone agonist trigger

    Daichi Inoue; Yoshihiko Sakakibara; Chiharu Ishida et al.

    Reproductive Medicine and Biology, Vol. 22 No. 1 · 2023 · English · DOAJ Scopus

    Abstract Purpose To analyze whether response to the GnRH test is a predictor of empty follicle syndrome (EFS) and to analyze independent risk factors for EFS. Methods The GnRH test results of 3765 patients from 2016 to 2018 were used to define the reference range of the GnRH test. Risk factors for…

  10. Journal Article

    Development of an AI‐based support system for controlled ovarian stimulation

    Yoshimasa Asada; Tomoya Shinohara; Sho Yonezawa et al.

    Reproductive Medicine and Biology, Vol. 23 No. 1 · 2024 · English · DOAJ Scopus

    Abstract Purpose Controlled ovarian stimulation (COS) is vital for IVF. We have developed an AI system to support the implementation of COS protocols in our clinical group. Methods We developed two models as AI algorithms of the AI system. One was the oocyte retrieval decision model, to determine…

  11. Journal Article

    Exploring the mechanistic link between SF3B1 mutation and ring sideroblast formation in myelodysplastic syndrome

    Tetsuro Ochi; Tohru Fujiwara; Koya Ono et al.

    Scientific Reports, Vol. 12 No. 1 · 2022 · English · DOAJ Scopus

    Abstract Acquired sideroblastic anemia, characterized by bone marrow ring sideroblasts (RS), is predominantly associated with myelodysplastic syndrome (MDS). Although somatic mutations in splicing factor 3b subunit 1 (SF3B1), which is involved in the RNA splicing machinery, are frequently found in…

  12. Journal Article

    In-depth functional analysis of BRD9 in fetal hematopoiesis reveals context-dependent roles

    Yifan Zhang; Masaki Nomura; Koutarou Nishimura et al.

    iScience, Vol. 28 No. 3 · 2025 · English · DOAJ Scopus

    Summary: The hierarchical organization of hematopoietic stem cells (HSCs) governing adult hematopoiesis has been extensively investigated. However, the dynamic epigenomic transition from fetal to adult hematopoiesis remains incompletely understood, particularly regarding the involvement of…

  13. Journal Article

    BRD4 and MYB inhibition overcomes venetoclax resistance in EVI1-rearranged acute myeloid leukemia

    Weijia Zang; Yui Koike; Koutarou Nishimura et al.

    Scientific Reports, Vol. 15 No. 1 · 2025 · English · DOAJ Scopus

    Abstract EVI1-rearranged acute myeloid leukemia (AML) with inv(3)(q21q26) or t(3;3)(q21q26) represents a distinct and aggressive subtype characterized by poor prognosis and limited treatment options. However, the optimal strategy to overcome resistance to conventional therapy remains elusive…

  14. Journal Article

    ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia

    Jean-Baptiste Micol; Alessandro Pastore; Daichi Inoue et al.

    Nature Communications, Vol. 8 No. 1 · 2017 · English · DOAJ Scopus

    While the role of ASLX1 in haematopoiesis and leukaemia has been heavily studied, the role of ASLX2 is unclear. Here the authors show that ASLX2 is required for normal haematopoietic stem cell self-renewal whereas Asxl2 loss promotes leukemogenesis, thus explaining the frequently observed mutations…

  15. Journal Article

    Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis

    Shuhei Asada; Susumu Goyama; Daichi Inoue et al.

    Nature Communications, Vol. 9 No. 1 · 2018 · English · DOAJ Scopus

    ASXL1 gene is often mutated in myeloid malignancies. Here, the authors show that mutant ASXL1 and BAP1 are in a positive feedback loop such that BAP1 induces monoubiquitination of mutant ASXL1, which in turn enhances BAP1 activity to potentiate myeloid transformation via HOXA clusters and IRF8.

  16. Journal Article

    Mutant ASXL1 induces age-related expansion of phenotypic hematopoietic stem cells through activation of Akt/mTOR pathway

    Takeshi Fujino; Susumu Goyama; Yuki Sugiura et al.

    Nature Communications, Vol. 12 No. 1 · 2021 · English · DOAJ Scopus

    ASXL1 mutations are frequently found in age-related clonal haemaotopoiesis (CH), but how they drive CH is unclear. Here the authors show that expression of C-terminal truncated ASXL1 in haematopoietic stem cells (HSCs) leads to Akt de-ubiquitination, activated Akt/mTOR signaling, and aberrant HSC…

  17. Journal Article

    BRD9 determines the cell fate of hematopoietic stem cells by regulating chromatin state

    Muran Xiao; Shinji Kondo; Masaki Nomura et al.

    Nature Communications, Vol. 14 No. 1 · 2023 · English · DOAJ Scopus

    Abstract ATP-dependent chromatin remodeling SWI/SNF complexes exist in three subcomplexes: canonical BAF (cBAF), polybromo BAF (PBAF), and a newly described non-canonical BAF (ncBAF). While cBAF and PBAF regulate fates of multiple cell types, roles for ncBAF in hematopoietic stem cells (HSCs) have…

  18. Journal Article

    ASXL1 mutations are associated with distinct epigenomic alterations that lead to sensitivity to venetoclax and azacytidine

    Nora E. Rahmani; Nandini Ramachandra; Srabani Sahu et al.

    Blood Cancer Journal, Vol. 11 No. 9 · 2021 · English · DOAJ Scopus

    Abstract The BCL2-inhibitor, Venetoclax (VEN), has shown significant anti-leukemic efficacy in combination with the DNMT-inhibitor, Azacytidine (AZA). To explore the mechanisms underlying the selective sensitivity of mutant leukemia cells to VEN and AZA, we used cell-based isogenic models…